Guecamburu, Marina
Coquelin, Anaëlle
Rapin, Amandine
Le Guen, Nelly
Solomiac, Agnès
Henrot, Pauline
Erbault, Marie
Morin, Sandrine
Zysman, Maéva
Article History
Received: 26 October 2022
Accepted: 9 March 2023
First Online: 7 April 2023
Declarations
:
: This work was carried out by the HAS (Haute Autorité de Santé) whose aim is to design COPD-specific quality of care indicators based on French guidelines and workshops with experts (GPs, pulmonologists, expert patients, pharmacists, nutritionists, physiotherapists, physical and rehabilitation physician, professional pathologist, public health physician). According to French Law [CitationRef removed], this anonymous retrospective observational database study does not require approval by an ethics committee or informed signed consent from the patients.
: MG, AC, AR, NLG, AS, ME, SM have no conflicts of interest to disclose. PH reports grants from Avad outside the submitted work. MZ reports grants and personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Chiesi, personal fees from AstraZeneca, personal fees from CSLBehring and personal fees from GSK outside the submitted work, grants from AVAD, grants from FRM.